Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 24, 1998

View Archived Issues

Tin complexes with antitumor activity disclosed by Pharmachemie

Antitumor agents isolated from Streptomyces by Japanese lab

Future antiglaucoma drug candidates added to the pipeline at Alcon

Potential cardiovascular agents act by increasing HDL cholesterol

MRI contrast agents reported by Hoechst Celanese

MDL-103294 and related antioxidants described by Hoechst Marion Roussel

Novel cysteine protease inhibitors discussed by BASF

Company Profile: Arachnova

Wound-healing asiatic acid derivatives under investigation at Dong Kook

Antimuscarinic agent KRP-197 shows potential for treating incontinence

Thymosin alpha 1 receives patent protection for hepatitis C indication

New indication approved for AmBisome in the U.K.

Corvas and Schering-Plough discontinue collaboration; other projects remain on track

Phytera and Tsumura Juntendo expand research collaboration

Access licensee files for U.K. approval of amlexanox oral paste

Fungal enzyme inhibitors synthesized at Nippon Roche

GeneMedicine reports progress in its development of dendritic cell-based genetic vaccines

EU approval granted for Novo's orally active antidiabetic agent NovoNorm

First European filing for TOBI

Antiinvasive activity demonstrated with Servier's zinc chelator/MMP inhibitor

Fluoroquinolone antibacterial available for licensing from Dong Wha

Imutec receives patent protection for Virulizin in Canada

Strategy to improve the bioavailability of anthelmintic agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...